(NYSE: QGEN) Qiagen Nv's forecast annual revenue growth rate of 6.62% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 8.52%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.54%.
Qiagen Nv's revenue in 2026 is $2,089,999,000.On average, 26 Wall Street analysts forecast QGEN's revenue for 2026 to be $492,403,470,000, with the lowest QGEN revenue forecast at $469,764,230,000, and the highest QGEN revenue forecast at $514,607,340,000. On average, 25 Wall Street analysts forecast QGEN's revenue for 2027 to be $520,484,835,000, with the lowest QGEN revenue forecast at $485,655,235,000, and the highest QGEN revenue forecast at $551,396,105,000.
In 2028, QGEN is forecast to generate $552,266,845,000 in revenue, with the lowest revenue forecast at $512,430,490,000 and the highest revenue forecast at $589,490,980,000.